New Drug Approvals Archive

New Drug Approvals: May 2007

May 2
Perlane (dermal filler)

Date of Approval: May 2, 2007

Company: Medicis

Treatment for: Facial Wrinkles

Perlane is a dermal filler for the correction of moderate to severe facial folds and wrinkles, such as nasolabial folds.

Medicis Announces FDA Approval of Perlane
 
May 3
Supprelin-LA (histrelin acetate) Subcutaneous Implant

Date of Approval: May 3, 2007

Company: Indevus Pharmaceuticals, Inc.

Treatment for: Precocious Puberty

Supprelin-LA is a once-yearly implant of the gonadotropin releasing hormone (GnRH) analog histrelin, indicated for the treatment of central precocious puberty (CPP), the premature onset of puberty in children.

Indevus Announces FDA Approval of Supprelin-LA
 
May 9
Neupro (rotigotine) Transdermal System

Date of Approval: May 9, 2007

Company: Schwarz Pharma

Treatment for: Parkinson's Disease

Neupro (rotigotine) is a non-ergolinic dopamine agonist transdermal system, administered once daily for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease.

FDA Approves Schwarz Pharma's Neupro (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease in USA
 
May 11
Perforomist (formoterol fumarate) Inhalation Solution

Date of Approval: May 11, 2007

Company: Dey, L.P.

Treatment for: Chronic Obstructive Pulmonary Disease

Perforomist is an inhalation solution formulation of the long-acting beta(2)-adrenergic agonist formoterol fumarate, indicated for the long-term, twice-daily maintenance treatment of bronchoconstriction for emphysema and chronic bronchitis, also known as Chronic Obstructive Pulmonary Disease (COPD).

FDA Approves Dey, L.P.'s Perforomist (Formoterol Fumarate) Inhalation Solution for Maintenance Treatment of COPD
 
May 18
Seroquel (quetiapine)

New Dosage Form Approved: May 17, 2007

FDA Approves Astrazeneca's Once-Daily Seroquel XR Extended-Release Tablets for the Treatment of Schizophrenia
 
May 22
Lybrel (levonorgestrel and ethinyl estradiol) Low Dose Continuous Regimen

Date of Approval: May 22, 2007

Company: Wyeth Pharmaceuticals Inc.

Treatment for: Contraception

Lybrel (levonorgestrel and ethinyl estradiol) is a low-dose combination contraceptive pill taken continuously (without a pill-free interval) and over time may eliminate scheduled menstrual periods. Lybrel is indicated for the prevention of pregnancy.

FDA Approves Lybrel, First Low Dose Combination Oral Contraceptive Offering Women the Opportunity to Be Period-Free Over Time
 
May 25
Xyzal (levocetirizine dihydrochloride)

Date of Approval: May 25, 2007

Company: UCB, Inc. and sanofi-aventis

Treatment for: Allergic Rhinitis, Allergic Urticaria

Xyzal (levocetirizine) is an antihistamine for the relief of symptoms associated with allergic rhinitis and urticaria.

FDA Approves Xyzal (Levocetirizine Dihydrochloride) Tablets for the Relief of Seasonal and Year Round Allergies, and Chronic Hives
 
May 30
Torisel (temsirolimus) Injection

Date of Approval: May 30, 2007

Company: Wyeth Pharmaceuticals, Inc.

Treatment for: Renal Cell Carcinoma

Torisel (temsirolimus), an inhibitor of mTOR kinase, is an antineoplastic agent indicated for the treatment of patients with advanced renal cell carcinoma.

FDA Approves Torisel, a Targeted First-in-Class mTOR Inhibitor for the Treatment of Advanced Kidney Cancer
 
February 19
Xyzal (levocetirizine dihydrochloride)

New Dosage Form Approved: January 28, 2008

FDA Approves Xyzal (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
 
August 25
Xyzal (levocetirizine dihydrochloride)

Patient Population Altered: August 21, 2009

FDA Approves Xyzal For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria
 

New Drug Approvals Archive

2009: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Feb | Jul | Aug | Oct | Nov | Dec

MedNotes
Advertisement

(web4)